Acrivon AB
559152-0944ActiveDeveloping targeted cancer therapies using proprietary proteomics platform.
Yleiskatsaus
- 10–19
- Työntekijät
- 20–50milj SEK
- Liikevaihto
- 2018
- Perustettu
Avainpäättäjät
Peter Blume-Jensen
CEO, President, Founder, Chairperson
Tiffany Crowell
Senior Vice President, Clinical Operations
David Proia
Senior Vice President, Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
+26 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Acrivon Therapeutics is a clinical-stage oncology company focused on developing targeted therapies to improve patient lives. They utilize their proprietary Acrivon Predictive Precision Proteomics (AP3) platform, which moves beyond traditional genomics. This platform generates unique OncoSignature co...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559152094401
Päättäjät
30 yhteystietoa FunnelfeedrissäPeter Blume-Jensen
CEO, President, Founder, Chairperson
Tiffany Crowell
Senior Vice President, Clinical Operations
David Proia
Senior Vice President, Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
Ivana Magovčević-Liebisch
Director
Michaela Levin
Chief Business Officer
Charles (Chuck) Baum
Director
Katharine Peterson
Vice President, Finance and Chief Accounting Officer
John van Duzer
Senior Vice President, Chemistry Manufacturing and Controls
Lu Gan
Senior Vice President, Clinical Development
Mansoor Raza Mirza
Chief Medical Officer
Joon Jung
Senior Vice President, Head of Data Science
Mary-Alice Miller
Chief Legal Officer
Michail Shipitsin
Vice President, Biomarker Development
Rajshree Kandadai
Head of Business Development
Adam D. Levy
Chief Financial Officer
Derek DiRocco
Director
Bruce Close
Vice President, Quality and Compliance
Praveen Marapaka
SVP, Global Regulatory Affairs
Jesper Olsen
Academic Co-Founder, Head of Phosphoproteomics
Kristina Masson
Co-Founder, EVP, Business Operations, Site Head, Director
Monica Phadnis
SVP, Clinical Operations
Sharon Shacham
Director
Christina Scherer
Vice President, Early Program Management
Erick Gamelin
Chief Development Officer
Santhosh Palani
Director
Michael Tomsicek
Director
Virna Schuck
VP of Clinical Pharmacology
Muut yhteyshenkilöt
Sam Rua
CDx Regulatory
Thomas P. Nifong
Clinical CDx Operations
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäAkiram Therapeutics AB
1–4 työntekijätPioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
MyCural Therapeutics AB
10–19 työntekijätDeveloping novel small molecule therapies targeting the MYC oncoprotein.
APIM THERAPEUTICS AS
Biotech company developing novel peptide therapeutics targeting cancer cell survival mechanisms.
Biovica International AB
10–19 työntekijätDeveloping blood tests to monitor cancer treatment efficacy.
Biovica Services AB
Developing blood tests to monitor cancer treatment efficacy.
Selaa lisää
Kysymyksiä yrityksestä Acrivon AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo